{"database": "lobbying", "table": "lobbying_activities", "rows": [[3487102, "3730a1e5-cad9-4d97-a589-d5c0d724e4bc", "Q4", "THE LIVINGSTON GROUP, LLC", 49635, "INNOVATIVE VACCINE TECHNOLOGIES", 2025, "fourth_quarter", "MED", "FY2026 appropriations for the development of a synthetic vaccine", null, null, null, 0, 0, "2026-01-15T15:51:30-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3487102"], "units": {}, "query_ms": 1.4420950319617987, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}